Advertisement

Citation tools

Jaglowski, Samantha M. et al "Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study." Blood (2015): blood-2014-12-617522. Web. 16 July. 2019.